Macpod CV 50 Powder for Oral Suspension contains Cefpodoxime Proxetil 50 mg and Clavulanic Acid 31.25 mg as active ingredients. Cefpodoxime Proxetil is a third-generation cephalosporin antibiotic with broad-spectrum activity against various Gram-positive and Gram-negative bacteria, while Clavulanic Acid acts as a beta-lactamase inhibitor, enhancing the efficacy of Cefpodoxime by preventing bacterial resistance. This combination is indicated for the treatment of a wide range of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and otitis media. The oral suspension formulation allows for ease of administration, particularly in pediatric and geriatric populations who may have difficulty swallowing tablets. Macpod CV 50 should be reconstituted with the specified amount of water before use and administered as directed by a healthcare professional. Dosage adjustments may be necessary based on the severity of infection, patient age, and renal function. Common adverse effects include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort, which are generally mild and transient. Patients with a history of hypersensitivity to cephalosporins or penicillins should use this medication with caution. Proper adherence to the prescribed regimen is essential to prevent the development of antibiotic resistance.